glp-1 gastric intestinal obstruction lawyer in kentucky constipation law office Ozempic Lawsuit [May 2026 Update] semaglutide gastric intestinal obstruction law
Description
CII Rx only Takeda PRINCIPAL DISPLAY PANEL - 40 mg Tablet Bottle Label NDC 59417-118-01 Vyvanse (lisdexamfetamine dimesylate) chewable tablets 40 mg 100 CHEWABLE TABLETS Chew tablets completely before swallowing
![glp-1 gastric intestinal obstruction lawyer in kentucky constipation law office Ozempic Lawsuit [May 2026 Update] semaglutide gastric intestinal obstruction law](https://www.elglaw.com/uploads/is-ileus-caused-by-semaglutide-treatable.jpg)
[Crossref] [PubMed] Mollan SP, Mitchell JL, Yiangou A, et al
![glp-1 gastric intestinal obstruction lawyer in kentucky constipation law office Ozempic Lawsuit [May 2026 Update] semaglutide gastric intestinal obstruction law](https://www.lawrencefirm.com/wp-content/uploads/2024/05/Ozempic-Lawsuit-Attorneys-e1772472125297.jpg)
If you have a family history of cardiovascular disease, existing risk factors like high blood pressure or elevated cholesterol, or a history of cardiac events, discuss the cardiovascular implications of discontinuation specifically with your provider
![glp-1 gastric intestinal obstruction lawyer in kentucky constipation law office Ozempic Lawsuit [May 2026 Update] semaglutide gastric intestinal obstruction law](https://i.ytimg.com/vi/7gg5QxzQggA/maxresdefault.jpg)
Key contraindications include pregnancy and breastfeeding, with caution advised in those with thyroid disease, pancreatitis history, or severe gastrointestinal disease
We conducted two new-user, active comparator cohort studies